Infinity Pharmaceuticals

Infinity Pharmaceuticals EBITDA Margin

The EBITDA Margin of Infinity Pharmaceuticals (INFIQ) as of Nov 20, 2026 is -1,729.43 %. In the previous year, EBITDA Margin was -2,426.43 % — a change of -28.73% (higher).

EBITDA Margin

-1,729.43 %

YoY

-28.73%

Last updated:

EBITDA Margin of Infinity Pharmaceuticals is 2022 -1,729.43 % . EBITDA Margin of Infinity Pharmaceuticals was 2021 -2,426.43 % . It decreases by -28.73% higher compared to the previous year.

The Infinity Pharmaceuticals EBITDA Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Margin
Date
EBITDA Margin
Jan 1, 2015
-116.50 USD
Jan 1, 2016
-765.24 USD
Jan 1, 2017
-606.67 USD
Jan 1, 2018
-53.85 USD
Jan 1, 2019
-1,497.67 USD
Jan 1, 2020
-2,239.50 USD
Jan 1, 2021
-2,426.43 USD
Jan 1, 2022
-1,729.43 USD
The Infinity Pharmaceuticals EBITDA Margin history
YEAREBITDA MarginYoY
-1,729.43 %-28.73%
-2,426.43 %+8.35%
-2,239.50 %+49.53%
-1,497.67 %+2,681.39%
-53.85 %-91.12%
-606.67 %-20.72%
-765.24 %+556.87%
-116.50 %+2,333.20%
-4.79 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Infinity Pharmaceuticals Stock analysis

What does Infinity Pharmaceuticals do? Infinity Pharmaceuticals Inc. is a biopharmaceutical company based in Cambridge, Massachusetts. It was founded in 2001 and focuses on the discovery and development of novel therapies for cancer and other serious diseases. Infinity Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Infinity Pharmaceuticals stock

EBITDA Margin of Infinity Pharmaceuticals is -1,729.43 % in 2022.

EBITDA Margin of Infinity Pharmaceuticals changed from -2,426.43 % to -1,729.43 %, representing a -28.73% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA Margin Infinity Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

EBITDA Margin shows what percentage of revenue converts to EBITDA. It normalizes for depreciation and capital structure differences.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBITDA Margin's Infinity Pharmaceuticals with sector peers and the industry average to assess whether it is attractive.

To evaluate EBITDA Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBITDA Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Infinity Pharmaceuticals

All Key Metrics — Infinity Pharmaceuticals